Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overuse of monitoring of blood concentrations of antiepileptic drugs.

Literature DB >> 3105708

Overuse of monitoring of blood concentrations of antiepileptic drugs.

D W Chadwick.

Abstract

Mesh：

Substances：
Anticonvulsants

Year: 1987 PMID： 3105708 PMCID： PMC1245787 DOI： 10.1136/bmj.294.6574.723

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

8 in total

1. Serum-phenytoin levels in management of epilepsy.

Authors: A Richens; A Dunlop
Journal: Lancet Date: 1975-08-09 Impact factor: 79.321

2. "Therapeutic" serum concentration of phenytoin: the influence of seizure type.

Authors: D M Turnbull; M D Rawlins; D Weightman; D W Chadwick
Journal: J Neurol Neurosurg Psychiatry Date: 1984-03 Impact factor: 10.154

3. Phenytoin kinetics during pregnancy and the puerperium.

Authors: C Knott; C P Williams; F Reynolds
Journal: Br J Obstet Gynaecol Date: 1986-10

4. One drug for epilepsy.

Authors: S D Shorvon; D Chadwick; A W Galbraith; E H Reynolds
Journal: Br Med J Date: 1978-02-25

5. The delayed effect of sodium valproate on the photoconvulsive response in man.

Authors: A J Rowan; C D Binnie; C A Warfield; H Meinardi; J W Meijer
Journal: Epilepsia Date: 1979-02 Impact factor: 5.864

6. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

Authors: P Loiseau; B Cenraud; R H Levy; R Akbaraly; A Brachet-Liermain; M Guyot; P L Morselli
Journal: Clin Pharmacokinet Date: 1982 Nov-Dec Impact factor: 6.447

7. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.

Authors: F Reynolds; P N Ziroyanis; N F Jones; S E Smith
Journal: Lancet Date: 1976-08-21 Impact factor: 79.321

8. Which drug for the adult epileptic patient: phenytoin or valproate?

Authors: D M Turnbull; D Howel; M D Rawlins; D W Chadwick
Journal: Br Med J (Clin Res Ed) Date: 1985-03-16

8 in total

10 in total

5. Use of plasma levels for antiepileptic drug monitoring in clinical practice. Gruppo Collaborativo per lo Studio dell'Epilessia.

Authors: E Beghi; D Trevisan; G Tognoni
Journal: Ital J Neurol Sci Date: 1992-02

Overuse of monitoring of blood concentrations of antiepileptic drugs.

1. Serum-phenytoin levels in management of epilepsy.

2. "Therapeutic" serum concentration of phenytoin: the influence of seizure type.

3. Phenytoin kinetics during pregnancy and the puerperium.

4. One drug for epilepsy.

5. The delayed effect of sodium valproate on the photoconvulsive response in man.

6. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.

7. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.

8. Which drug for the adult epileptic patient: phenytoin or valproate?

Review 1. Medical assessment and treatment of chronic epilepsy.

Review 2. Therapeutic drug monitoring--antiepileptic drugs.

Review 3. Is there a role for therapeutic drug monitoring of new anticonvulsants?

Review 4. Disposition of anticonvulsants in childhood.

5. Use of plasma levels for antiepileptic drug monitoring in clinical practice. Gruppo Collaborativo per lo Studio dell'Epilessia.

6. Rapid anticonvulsant monitoring in an epilepsy clinic.

Review 7. The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research.

Review 8. Therapeutic monitoring of antiepileptic drugs for epilepsy.

9. Measure for Measure: Measuring the Usefulness of Measuring Antiseizure Medication Levels.

10. Monitoring antiepileptic drugs: a level-headed approach.